Company intelligence / Profile preview

Ryzur Medical Investment

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Ryzur Medical is a leading provider in China for rehabilitation medical technology, equipment, and comprehensive medical services, with a focus on neurological and orthopedic rehabilitation. It manages hospitals, supplies over 200 models of rehabilitation equipment, and is investing in wearable medical robotics for upper limb paralysis through a joint venture with Myomo to bring the MyoPro powered arm brace to China.[1]

Therapeutic areas: Neurology
Modalities: Device
Industry: Non-Academic Healthcare

Partnerships

MyomoChinaleaf Capital

Beyond the preview

Go deeper on Ryzur Medical Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ryzur Medical Investment.

Explore the full profile